Overview

A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers

Status:
COMPLETED
Trial end date:
2025-02-22
Target enrollment:
Participant gender:
Summary
The purposes of this Phase 1 study of sevasemten are to: 1. Evaluate the effect of multiple-dose administration of verapamil on the single-dose of sevasemten in healthy adults 2. Evaluate the safety and tolerability of a single dose of sevasemten administered with and without verapamil in healthy adult subjects. 3. Evaluate the safety and tolerability of a single dose of sevasemten administered with and without food in healthy adult subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Edgewise Therapeutics, Inc.
Treatments:
Verapamil